Introducing the ViennaLab SARS-CoV-2 RealFast Assay – the gold standard in rapid and highly sensitive SARS-CoV-2 identification. SARS-CoV-2 is a positive sense, single stranded RNA respiratory virus that emerged in late 2019, and has since become a global pandemic. With the silent spread of the virus, it’s essential to test individuals without clinical or subclinical symptoms who may have been exposed to control the pandemic locally, regionally, and globally.

This highly sensitive assay allows for the detection of two viral target genes (N and RdRP/ORF1ab), specific to SARS-CoV-2, in a one-tube reaction. The RealFast Assay is a multiplex one-tube reaction assay that includes a human ACTB gene-detecting control, with a high sensitivity of LoD: 10 copies per reaction, ensuring accurate results. Additionally, the assay has successfully passed external quality assessment schemes and is compatible with a wide range of real-time PCR instruments.

As several countries temporarily reduce the number of daily new cases, robust diagnostic tools that facilitate the efficient control of new outbreaks remain highly demanded. The RealFast Assay provides a quick and sensitive testing method using real-time reverse transcription PCR technology, ensuring accurate detection of current infections.